Novorapid 100 Units/ml Vial 10 Ml

NOVORAPID 100 UNITS/ML VIAL 10 ML

NovoRapid 100 Units/mL Vial 10 mL is a rapid-acting insulin analogue used for managing blood sugar levels in individuals with diabetes mellitus. It is manufactured by Novo Nordisk.

Name

• Brand Name: NovoRapid
• Common Name: Insulin Aspart

Composition

• Active Ingredient: Each mL contains 100 units of Insulin Aspart (recombinant DNA origin).
• Other Ingredients: Glycerol, phenol, metacresol, zinc chloride, sodium chloride, dibasic sodium phosphate dihydrate, sodium hydroxide, hydrochloric acid, and water for injections.

Uses

NovoRapid is prescribed for the treatment of diabetes mellitus in adults, adolescents, and children aged 1 year and above. As a rapid-acting insulin, it is primarily used to control hyperglycemia (high blood sugar levels), especially post-meal blood sugar spikes. It is typically administered in regimens that also include an intermediate-acting or long-acting insulin. NovoRapid 10 mL vials can also be used for continuous subcutaneous insulin infusion (CSII) in compatible pump systems. In emergency situations, it may be administered intravenously under strict medical supervision.

Dosage and Administration

The dosage of NovoRapid is individualized by a physician according to the patient's specific needs. The usual individual daily insulin requirement ranges between 0.5 and 1.0 units/kg/day in adults and children. NovoRapid should generally be given immediately (up to 10 minutes) before a meal or, if necessary, soon after the start of a meal.

It is administered as a subcutaneous injection into the abdominal wall, thigh, upper arm, deltoid, or gluteal region. Injection sites should be rotated within the same region to minimize the risk of lipodystrophy (skin changes) and cutaneous amyloidosis (lumps under the skin). When used with an insulin infusion pump, NovoRapid should not be mixed with any other medicinal products, and the infusion set and reservoir should be changed every 48 hours or as per pump manufacturer's instructions.

Side Effects

• Common Side Effects: The most frequent side effect is hypoglycemia (low blood sugar levels), which can manifest as cold sweat, nervousness, shakiness, fast heartbeat, headache, hunger, confusion, lightheadedness, weakness, numbness or tingling of the lips, fingers, or tongue, blurred vision, dizziness, drowsiness, and difficulty concentrating. Other common effects include injection site reactions (pain, redness, itching, bruising, swelling), lipodystrophy, cutaneous amyloidosis, temporary visual problems, and swollen hands and feet. Weight gain may also occur.
• Serious Side Effects: Severe hypoglycemia can lead to disorientation, seizures, loss of consciousness, brain damage, or even death. Rare but serious allergic reactions (e.g., widespread skin rashes, shortness of breath, swelling of the face/lips/tongue, fast pulse, sweating) may occur. Patients with pre-existing heart conditions using certain diabetes medications (thiazolidinediones) in combination with insulin may experience signs of heart failure. Hypokalemia (low potassium levels) is also a possible side effect.

Precautions

Do not use NovoRapid if you are allergic to insulin aspart or any of its excipients, or if you suspect hypoglycemia is starting. Regular monitoring of blood sugar levels is crucial, and a sugary food or drink should always be carried to treat potential hypoglycemia. Inform your doctor about any kidney, liver, or gland problems, as well as all other medicines you are taking, as they may interact with insulin and require dose adjustments. Alcohol consumption can affect blood sugar levels and should be monitored carefully. If you are pregnant or breastfeeding, NovoRapid can be used, but your insulin dose may need adjustment. Patients should exercise caution when driving or operating machinery, as blood sugar fluctuations can impair concentration and reaction time. Always use a new needle for each injection, and never share pens or needles. Do not dilute NovoRapid or mix it with other medicines when using it in an infusion pump.

Storage

Unopened NovoRapid vials should be stored in a refrigerator between 2°C and 8°C. Do not freeze NovoRapid. Vials that are in use or carried as a spare can be kept at a temperature below 30°C or in a refrigerator (2°C - 8°C) for a maximum of 4 weeks. Protect the medicine from excessive heat and light. Do not use if the solution is not clear and colorless, and never use it after the expiry date printed on the label and carton. Keep out of the reach of children.

Frequently Asked Questions about NOVORAPID 100 UNITS/ML VIAL 10 ML

What is NovoRapid used for?

NovoRapid (insulin aspart) is a fast-acting insulin used to manage high blood sugar levels in adults, adolescents, and children aged 1 year and above with diabetes mellitus (type 1 and type 2). It helps prevent complications associated with diabetes.

How does NovoRapid work?

NovoRapid is a modern insulin analogue that works rapidly to lower blood sugar levels. It starts to act within 10 to 20 minutes after injection, reaches its maximum effect between 1 and 3 hours, and its effects can last for 3 to 5 hours. It functions by stimulating the uptake of sugar into muscle and fat cells and suppressing sugar production in the liver.

What is the usual dosage of NovoRapid?

The dosage of NovoRapid is individualized and determined by a doctor based on the patient's specific needs. It is typically used in combination with intermediate-acting or long-acting insulin. The usual daily insulin requirement for adults and children is generally between 0.5 and 1.0 units/kg/day. In a basal-bolus regimen, NovoRapid may provide 50-70% of this requirement, with the rest coming from longer-acting insulin.

What are the possible side effects of NovoRapid?

The most common side effect is low blood sugar (hypoglycemia), which can cause symptoms like cold sweat, pale skin, headache, rapid heartbeat, hunger, confusion, and dizziness. Other possible side effects at the injection site include pain, redness, hives, inflammation, bruising, swelling, and itching. Some patients may experience skin changes like thickening, shrinking, or lumps under the skin (lipodystrophy) at the injection site, which can be reduced by rotating injection sites. In rare cases, more serious allergic reactions can occur.

Is NovoRapid safe during pregnancy or breastfeeding?

NovoRapid can be used during pregnancy. However, intensified blood glucose control and monitoring are recommended, as insulin needs typically decrease in the first trimester and increase in the second and third trimesters. There are no restrictions on using NovoRapid while breastfeeding, but the dosage may need adjustment.

Can NovoRapid be taken with other medications?

Yes, but several medications can interact with NovoRapid and affect blood glucose levels. Some medications may reduce insulin requirements (e.g., oral antidiabetic medicines, MAOIs, beta-blockers, ACE inhibitors, salicylates, anabolic steroids, sulfonamides). Others may increase insulin requirements (e.g., oral contraceptives, thiazides, glucocorticoids, thyroid hormones, sympathomimetics, growth hormone, danazol). Beta-blockers may also mask the symptoms of hypoglycemia. It is crucial to inform your doctor about all medicines you are taking, including over-the-counter drugs and herbal supplements.

What precautions should be taken?

Always check the label to ensure it is the correct type of insulin. Measure blood sugar levels regularly and carry sugary food or fruit juice in case of low blood sugar. Rotate injection sites to prevent skin changes. Do not stop using NovoRapid unless advised by your doctor. Avoid consuming alcohol, as it can affect blood sugar levels and mask hypoglycemia symptoms. If you have frequent low blood sugar episodes or difficulty recognizing them, discuss driving or operating machinery with your doctor.

What happens if a dose is missed?

If you miss a dose, use it as soon as you remember, but ensure you eat some carbohydrates within 10 minutes of the injection. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double the dose to compensate for a missed one. Missing doses can lead to high blood sugar levels (hyperglycemia).

How should NovoRapid be stored?

Unused NovoRapid vials should be stored in a refrigerator between 2°C and 8°C, away from the freezer. Do not freeze it. Once a vial is in use or carried as a spare, it can be stored at room temperature (below 30°C) or in a refrigerator (2°C to 8°C) for up to 4 weeks. After 4 weeks, the vial should be discarded, even if there is still medicine left.